Epilepsy in children: The evidence for new antiepileptic drugs

Acta Neurologica Scandinavica, Supplement

Volumn 112, Issue 181, 2005, Pages 17-20

  Verdru, Peter ^a  

^a UCB   (United States)

Author keywords

Antiepileptic drugs; Children; Levetiracetam; Management; Partial seizures; Refractory

Indexed keywords

ANTICONVULSIVE AGENT; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; NEW DRUG; OXCARBAZEPINE; PLACEBO; TOPIRAMATE; 4 AMINOBUTYRIC ACID; AMINE; CARBAMAZEPINE; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; DRUG DERIVATIVE; FRUCTOSE; TRIAZINE DERIVATIVE; VALPROIC ACID;

ADJUVANT THERAPY; BENIGN CHILDHOOD EPILEPSY; CHILD; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG ELIMINATION; DRUG SAFETY; DRUG TOLERABILITY; EPILEPSY; FOCAL EPILEPSY; HUMAN; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; ARTICLE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DRUG COMBINATION; TREATMENT OUTCOME; UNITED STATES; ADD ON THERAPY; AMERICAN ACADEMY OF NEUROLOGY; ANTICONVULSANT THERAPY; DISEASE CLASSIFICATION; DRUG DOSE TITRATION; DRUG WITHDRAWAL; MEDICAL SOCIETY; OUTCOMES RESEARCH; UNSPECIFIED SIDE EFFECT;

AMINES; ANTICONVULSANTS; CARBAMAZEPINE; CHILD; CROSS-SECTIONAL STUDIES; CYCLOHEXANECARBOXYLIC ACIDS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; FRUCTOSE; GAMMA-AMINOBUTYRIC ACID; HUMANS; PRACTICE GUIDELINES; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME; TRIAZINES; UNITED STATES;

EID: 28044456315     PISSN: 00651427     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. PELLOCK JM, WATEMBERG N. New antiepileptic drugs in children: present and future. Sem Pediatr Neurol 1997;4:9-18.
2. PELLOCK JM. Managing pediatric epilepsy syndromes with new antiepileptic drugs. Pediatrics 1999;104:1106-16.
3. PERUCCA E. Pharmacological problems in the management of epilepsy in children. Seizure 1995;4:139-43.
4. MIKAELOFF Y, REY E, SOUFFLET C et al. Topiramate pharmacokinetics in children with epilepsy aged from 6 months to 4 years. Epilepsia 2004;45:1448-52.
5. MIKATI MA, FAYAD M, KOLEILAT M et al. Efficacy, tolerability, and kinetics of lamotrigine in infants. J Pediatr 2002;141:31-5.
6. FRENCH JA, KANNER AM, BAUTISTA J et al. CME efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy. Neurology 2004;62:1261-73.
7. APPLETON R, FICHTNER K, LAMOREAUX L et al. Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicentre, double-blind, placebo-controlled study. Gabapentin Paediatric Study Group. Epilepsia 1999;40:1147-54.
8. DUCHOWNY M, PELLOCK JM, GRAF WD et al. A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Lamictal Pediatric Partial Seizure Study Group. Neurology 1999;53:1724-31.
9. ELTERMAN RD, GLAUSER TA, WYLLIE E, REIFE R, WU SC, PLEDGER G. A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group. Neurology 1999;52:1338-44.
10. GLAUSER TA, NIGRO M, SACHDEO R et al. Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group. Neurology 2000;54:2237-44.
11. PATSALOS PN. Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Pharmacol Ther 2000;85:77-85.
12. SHORVON SD, LOWENTHAL A, JANZ D, BIELEN E, LOISEAU P. Multicenter double-blind, randomised, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. Epilepsy 2000;41:1179-86.
13. CEREGHINO JJ, BITON V, ABOU-KHALIL B, DREIFUSS F, GAUER LJ, LEPPIK I. Levetiracetam for partial seizures: results of a double-blind, randomised clinical trial. Neurology 2000;55:236-42.
14. BEN-MENACHEM E, FALTER U. Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial onset seizures: a multicentre, double-blind, responder-selected study evaluating monotherapy. Epilepsia 2000;41:1276-83.
15. GLAUSER TA, PELLOCK JM, BEBIN M et al. Efficacy and safety of levetiracetam in children with partial seizures: an open-label trial. Epilepsia 2002;43:518-24.
16. GLAUSER TA, GAUER LJ, CHEN L. LEV N159 PEDIATRIC STUDY GROUP. Multicenter, double-blind placebo-controlled trial of adjunctive levetiracetam (Keppra®) therapy up to 60 mg/kg/day in pediatric patients with refractory partial epilepsy. Epilepsia 2004;45(Suppl. 7):186. (Abstract).